Prestige Consumer Healthcare Inc. (NYSE: PBH) is -3.10% lower on its value in year-to-date trading and has touched a low of $51.70 and a high of $63.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PBH stock was last observed hovering at around $58.41 in the last trading session, with the day’s gains setting it 0.36% off its average median price target of $67.00 for the next 12 months. It is also 18.37% off the consensus price target high of $72.00 offered by 6 analysts, but current levels are 2.05% higher than the price target low of $60.00 for the same period.
Currently trading at $58.77, the stock is 0.43% and 3.45% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing 0.62% at the moment leaves the stock 2.12% off its SMA200. PBH registered 11.77% gain for a year compared to 6-month loss of 1.38%. The firm has a 50-day simple moving average (SMA 50) of $4.04 and a 200-day simple moving average (SMA200) of $12.25.
The stock witnessed a 3.71% gain in the last 1 month and extending the period to 3 months gives it a 10.39%, and is 2.16% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.29% over the week and 2.36% over the month.
Prestige Consumer Healthcare Inc. (PBH) has around 535 employees, a market worth around $2.95B and $1.09B in sales. Current P/E ratio is 14.55 and Fwd P/E is 13.10. Profit margin for the company is 18.90%. Distance from 52-week low is 13.67% and -7.92% from its 52-week high. The company has generated returns on investments over the last 12 months (8.80%).
Prestige Consumer Healthcare Inc. (PBH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Prestige Consumer Healthcare Inc. (PBH) is a “Buy”. 6 analysts offering their recommendations for the stock have an average rating of 1.60, where 1 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Prestige Consumer Healthcare Inc. is expected to release its quarterly report on 11/03/2022.The EPS is expected to grow by 24.10% this year.
Prestige Consumer Healthcare Inc. (PBH) Top Institutional Holders
The shares outstanding are 50.36M, and float is at 49.52M with Short Float at 2.50%.
Prestige Consumer Healthcare Inc. (PBH) Insider Activity
A total of 34 insider transactions have happened at Prestige Consumer Healthcare Inc. (PBH) in the last six months, with sales accounting for 23 and purchases happening 11 times. The most recent transaction is an insider sale by Lombardi Ronald M.,the company’sChief Executive Office. SEC filings show that Lombardi Ronald M. sold 52,367 shares of the company’s common stock on Nov 12 at a price of $62.78 per share for a total of $3.29 million. Following the sale, the insider now owns 0.16 million shares.
Prestige Consumer Healthcare Inc. (PBH): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 0.39% up over the past 12 months and Pfizer Inc. (PFE) that is 24.21% higher over the same period. The Procter & Gamble Company (PG) is 3.00% up on the 1-year trading charts.